TORONTO, ONTARIO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – With the high demand for Covid-19 testing, BioLife Sciences (OTCPK: BLFE) is pleased to announce the availability of the FebriDx® ...
Detailed price information for Biolife Solutions (BLFS-Q) from The Globe and Mail including charting and trades.
Management issued 2026 guidance for total revenue between $112 million and $115 million, representing growth of 17% to 20%. de Greef said, "we see continued operating and adjusted EBITDA margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results